Youlei Wang Selected Research

feifukang

8/2018

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Youlei Wang Research Topics

Disease

6	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 09/2015
2	Fibrosis (Cirrhosis) 01/2020 - 01/2018
2	Idiopathic Pulmonary Fibrosis 12/2018 - 10/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2018
1	Brain Ischemia (Cerebral Ischemia) 03/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2009
1	Cerebral Infarction 03/2009
1	Ischemia 03/2009

Drug/Important Bio-Agent (IBA)

3	Long Noncoding RNAIBA 01/2021 - 10/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 08/2018
2	CollagenIBA 01/2021 - 08/2018
2	astaxanthine (astaxanthin)IBA 01/2020 - 09/2015
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
2	Messenger RNA (mRNA)IBA 12/2018 - 10/2017
2	RNA (Ribonucleic Acid)IBA 08/2018 - 01/2018
1	EstersIBA 01/2021
1	VimentinIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	Benzoates (Benzoate)IBA 01/2021
1	engeletinIBA 01/2021
1	Janus KinasesIBA 12/2018
1	Circular RNAIBA 12/2018
1	Competitive Endogenous RNAIBA 12/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Protein Kinases (Protein Kinase)IBA 12/2018
1	feifukangIBA 08/2018
1	astilbinIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Neuroprotective AgentsIBA 03/2009
1	AntioxidantsIBA 03/2009
1	2- (6- (2- carboxyvinyl)- 2,3- dihydroxyphenyl)- 3- (3,4- dihydroxyphenyl)acrylic acidIBA 03/2009
1	salvianolic acid BIBA 03/2009

Therapy/Procedure

1	Therapeutics 12/2018
1	Intravenous Injections 03/2009